Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic April 5, 2021
Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million March 22, 2021
Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy March 22, 2021
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology March 12, 2021
Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference March 8, 2021
Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference February 25, 2021